New injection aims to hold off chemotherapy for older men with tough prostate cancer
NCT ID NCT07161778
Summary
This study tested whether a steroid drug called triamcinolone, given as a monthly muscle injection alongside standard hormone therapy, could help control advanced prostate cancer that had stopped responding to initial treatments. It involved 55 men, mostly over 70, with the goal of extending the time their cancer was kept in check and delaying the need for more toxic chemotherapy. Researchers hoped this unique steroid might work where others fail because the cancer is not known to resist it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CASTRATION-RESISTANT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Raigmore Hospital
Inverness, United Kingdom
-
Royal Sussex County Hospital
Brighton, United Kingdom
-
St Bartholomew's Hospital
London, United Kingdom
Conditions
Explore the condition pages connected to this study.